The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid-Based Multiplex Assays Market Research Report 2024
Synopsis
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
The global Nucleic Acid-Based Multiplex Assays market was valued at US$ 512 million in 2023 and is anticipated to reach US$ 820.9 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
A significant driver in the Nucleic Acid-Based Multiplex Assays market is the growing demand for rapid and comprehensive diagnostics, particularly in the fields of infectious diseases and genomics research. Multiplex assays enable the simultaneous detection of multiple nucleic acid targets in a single test, offering efficiency and cost-effectiveness. However, a notable challenge in this market is the need for assay standardization and data analysis. Ensuring that multiplex assays provide consistent and reliable results across different platforms and that data interpretation remains accessible while addressing potential challenges in assay design and optimization poses a significant challenge. Manufacturers and healthcare providers must collaborate to establish standards, streamline assay workflows, and develop user-friendly data analysis tools to maximize the potential of nucleic acid-based multiplex assays in various diagnostic and research applications.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid-Based Multiplex Assays.
Report Scope
The Nucleic Acid-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid-Based Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
The global Nucleic Acid-Based Multiplex Assays market was valued at US$ 512 million in 2023 and is anticipated to reach US$ 820.9 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
A significant driver in the Nucleic Acid-Based Multiplex Assays market is the growing demand for rapid and comprehensive diagnostics, particularly in the fields of infectious diseases and genomics research. Multiplex assays enable the simultaneous detection of multiple nucleic acid targets in a single test, offering efficiency and cost-effectiveness. However, a notable challenge in this market is the need for assay standardization and data analysis. Ensuring that multiplex assays provide consistent and reliable results across different platforms and that data interpretation remains accessible while addressing potential challenges in assay design and optimization poses a significant challenge. Manufacturers and healthcare providers must collaborate to establish standards, streamline assay workflows, and develop user-friendly data analysis tools to maximize the potential of nucleic acid-based multiplex assays in various diagnostic and research applications.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid-Based Multiplex Assays.
Report Scope
The Nucleic Acid-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid-Based Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents & Consumables
1.2.3 Instruments & Accessories
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Companion Diagnostics
1.3.3 Research & Development
1.3.4 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2019-2030)
2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Region
2.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Size by Region (2019-2024)
2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Region (2025-2030)
2.3 Nucleic Acid-Based Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid-Based Multiplex Assays Industry Trends
2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers
2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges
2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue
3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2023
3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2019-2024)
4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2025-2030)
5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2019-2024)
5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2019-2030)
6.2 North America Nucleic Acid-Based Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2019-2024)
6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2019-2030)
7.2 Europe Nucleic Acid-Based Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2019-2024)
7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2019-2030)
9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2019-2024)
9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex
11.1.1 Luminex Company Detail
11.1.2 Luminex Business Overview
11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction
11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.1.5 Luminex Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction
11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 Bio-Rad Lab
11.4.1 Bio-Rad Lab Company Detail
11.4.2 Bio-Rad Lab Business Overview
11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction
11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.4.5 Bio-Rad Lab Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction
11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.6.5 BD Recent Development
11.7 Abcam
11.7.1 Abcam Company Detail
11.7.2 Abcam Business Overview
11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction
11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.7.5 Abcam Recent Development
11.8 Seegene
11.8.1 Seegene Company Detail
11.8.2 Seegene Business Overview
11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction
11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.8.5 Seegene Recent Development
11.9 Meso Scale Diagnostics
11.9.1 Meso Scale Diagnostics Company Detail
11.9.2 Meso Scale Diagnostics Business Overview
11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction
11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.9.5 Meso Scale Diagnostics Recent Development
11.10 Randox Laboratories
11.10.1 Randox Laboratories Company Detail
11.10.2 Randox Laboratories Business Overview
11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction
11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2019-2024)
11.10.5 Randox Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
